Literature DB >> 22056593

Assessing bleeding risk in acute coronary syndromes.

Guliz Erdem, Marcus Flather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22056593     DOI： 10.1016/j.recesp.2011.08.005

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  4 in total

1.  Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Authors:  Essa Hariri; Darleen Lessard; Joel Gore; Jeffrey Rade; Robert Goldberg
Journal:  Cardiovasc Revasc Med       Date:  2019-05-02

2.  Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary Syndromes.

Authors:  Roberto Martín-Asenjo; John Gregson; Xavier Rossello; Frans Van de Werf; Jesús Medina; Nicolas Danchin; Stuart Pocock; Héctor Bueno
Journal:  J Cardiovasc Transl Res       Date:  2021-01-08       Impact factor: 4.132

3.  Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1).

Authors:  Mohamad Jarrah; Ayman Hammoudeh; Osama Okkeh; Yousef Khader; Sahem Gharaibeh; Laith Nasser; Amro Rasheed; Ayed Al-Hindi; Mohammad Mohealdeen; Haneen Kharabsheh; Hanan Abunimeh; Enas Hijjih; Lina Tashman; Delia Omar; Nadeen Kufoof
Journal:  Anatol J Cardiol       Date:  2017-03-22       Impact factor: 1.596

4.  Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score.

Authors:  Ayman Morttada; Sameh Shahin
Journal:  Egypt Heart J       Date:  2018-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.